Your browser doesn't support javascript.
loading
Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum.
Mwaiswelo, Richard O; Mawala, William; Iversen, Per O; de Montalembert, Mariane; Luzzatto, Lucio; Makani, Julie.
Afiliação
  • Mwaiswelo RO; Department of Microbiology, Immunology and Parasitology, Hubert Kairuki Memorial University, Dar es Salaam, Tanzania. richiemwai@yahoo.com.
  • Mawala W; Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. richiemwai@yahoo.com.
  • Iversen PO; Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • de Montalembert M; Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Luzzatto L; Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Makani J; Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.
Malar J ; 19(1): 165, 2020 Apr 25.
Article em En | MEDLINE | ID: mdl-32334583
ABSTRACT

BACKGROUND:

Patients with sickle cell disease (SCD), an inherited haemoglobinopathy, have increased risk of malaria, at least in part due to impaired splenic function. Infection with Plasmodium falciparum in SCD patients can trigger painful vaso-occlusive crisis, increase the severity of anaemia, and contribute to early childhood mortality. CASE PRESENTATION A 17 year-old Tanzanian male with known SCD was admitted to Muhimbili National Hospital, a tertiary referral centre in Dar-es-Salaam, following an attack of malaria. From 2004 to 2007 the patient had lived in USA, and from 2010 to 2016 in France where, on account of hypersplenism and episodes of splenic sequestrations, in 2014 the spleen was removed. After appropriate clinical and laboratory assessment the patient was re-started on hydroxyurea; and anti-malarial-prophylaxis with proguanil was instituted. The patient has remained well and malaria-free for the following 15 months.

CONCLUSION:

SCD patients are highly vulnerable to malaria infection, and impaired splenic function is a feature of SCD patients, even in those who still anatomically have a spleen. This patient had a surgical splenectomy and, in addition, had probably lost some of the acquired malaria-immunity by having lived for several years in malaria-free areas. This patient is a compelling reminder that long-term anti-malarial prophylaxis should be offered to all patients with SCD who live in malaria-endemic areas.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proguanil / Malária Falciparum / Hidroxiureia / Anemia Falciforme / Antimaláricos / Antidrepanocíticos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Malar J Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tanzânia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proguanil / Malária Falciparum / Hidroxiureia / Anemia Falciforme / Antimaláricos / Antidrepanocíticos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Malar J Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tanzânia